Mad1 destabilizes p53 by preventing PML from sequestering MDM2
Mad1 is well characterised for its function in mitosis. Here, the authors describe an interphase role for Mad1 in tumour promotion in which it destabilises p53 by localizing to PML nuclear bodies and displacing MDM2 from the PML-MDM2 complex.
Guardado en:
Autores principales: | Jun Wan, Samuel Block, Christina M. Scribano, Rebecca Thiry, Karla Esbona, Anjon Audhya, Beth A. Weaver |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2325e2e3c5334028a09c465010f83a6c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Sarah E. Woodfield, et al.
Publicado: (2021) -
The MDM2-p53 pathway is involved in preconditioning-induced neuronal tolerance to ischemia
por: Rebeca Vecino, et al.
Publicado: (2018) -
Predicted functions of MdmX in fine-tuning the response of p53 to DNA damage.
por: Sohyoung Kim, et al.
Publicado: (2010) -
EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction
por: Jing Zhao, et al.
Publicado: (2021) -
Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Sarah E. Woodfield, et al.
Publicado: (2021)